These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33314490)

  • 21. Intralesional immunotherapy for pediatric warts: A review.
    Fields JR; Saikaly SK; Schoch JJ
    Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of interferon gamma in the prediction of successful therapy of common warts by intralesional injection of Candida antigen.
    Nofal A; Marei A; Amer A; Amen H
    Int J Dermatol; 2017 Oct; 56(10):1003-1009. PubMed ID: 28791682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intralesional Candida albicans antigen versus intralesional zinc sulfate in treatment of cutaneous warts.
    Youssef EMK; Eissa MAA; Bakr RM
    Arch Dermatol Res; 2023 Jul; 315(5):1305-1314. PubMed ID: 36567351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens.
    Clifton MM; Johnson SM; Roberson PK; Kincannon J; Horn TD
    Pediatr Dermatol; 2003; 20(3):268-71. PubMed ID: 12787281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candida albicans intralesional injection immunotherapy of warts.
    Signore RJ
    Cutis; 2002 Sep; 70(3):185-92. PubMed ID: 12353895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralesional Candida antigen versus intralesional vitamin D3 in the treatment of recalcitrant multiple common warts.
    Abdel Razik LH; Obaid ZM; Fouda I
    J Cosmet Dermatol; 2021 Oct; 20(10):3341-3346. PubMed ID: 34228877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of recalcitrant warts with Bacillus Calmette-Guérin: a promising new approach.
    Nofal A; Yosef A; Salah E
    Dermatol Ther; 2013; 26(6):481-5. PubMed ID: 24552412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts.
    Nofal AA; Elkholy BM; Abd-Elmonsef ER; Nofal HO
    Dermatol Ther (Heidelb); 2022 May; 12(5):1225-1237. PubMed ID: 35449500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-year experience with candida antigen immunotherapy for warts and molluscum.
    Maronn M; Salm C; Lyon V; Galbraith S
    Pediatr Dermatol; 2008; 25(2):189-92. PubMed ID: 18429776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intralesional immunotherapy for non-genital warts: A systematic review and meta-analysis.
    Ju HJ; Park HR; Kim JY; Kim GM; Bae JM; Lee JH
    Indian J Dermatol Venereol Leprol; 2022; 88(6):724-737. PubMed ID: 35962514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
    Nofal A; Alakad R
    J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Study of Intralesional Vitamin D3 Injection and Candida Albicans Antigen in Treating Plantar Warts.
    Abdelaal MA; Abdelaziz HM; Ahmed KA; Elsaie ML
    J Drugs Dermatol; 2021 May; 20(5):546-549. PubMed ID: 33938709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature.
    Aldahan AS; Mlacker S; Shah VV; Kamath P; Alsaidan M; Samarkandy S; Nouri K
    Dermatol Ther; 2016 May; 29(3):197-207. PubMed ID: 26991521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts.
    Tawfik NZ; Eyada MMK; Abdel El Hamid RE; Halim HM
    Dermatol Ther; 2022 Oct; 35(10):e15762. PubMed ID: 36056784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study between intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts.
    Eldahshan RM; Ashry WMO; Elsaie ML
    J Cosmet Dermatol; 2022 Mar; 21(3):1120-1126. PubMed ID: 34998000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralesional Quadrivalent Human Papilloma Virus Vaccine Versus Candida Antigen in the Treatment of Multiple Recalcitrant Non-Genital Warts.
    Fouda I; Mohammed HAK; Mohammed GMY
    Dermatol Pract Concept; 2024 Apr; 14(2):. PubMed ID: 38810062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined oral isotretinoin and Candida antigen versus either agent alone in the treatment of plane warts.
    Nofal A; Khedr A; Fathy M
    J Dermatolog Treat; 2022 Feb; 33(1):342-347. PubMed ID: 32271637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intralesional versus intramuscular bivalent human papillomavirus vaccine in the treatment of recalcitrant common warts.
    Nofal A; Marei A; Ibrahim AM; Nofal E; Nabil M
    J Am Acad Dermatol; 2020 Jan; 82(1):94-100. PubMed ID: 31369771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of mannose binding lectin in response to candida antigen immunotherapy of warts.
    Nasr M; Marie A; Boghdadi G; Elsaid R; Salah E
    J Dermatolog Treat; 2021 Jun; 32(4):376-380. PubMed ID: 31469597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood toll-like receptor 4 correlates response to candida immunotherapy of warts.
    Sabry HH; Hamed AM; Salem RM; Marei AM; El Sebaey RM
    Dermatol Ther; 2018 Sep; 31(5):e12691. PubMed ID: 30226014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.